Dr Chong Kian Tai | Farrer Park Hospital

Working hours

Biodata

Dr. Chong Kian Tai is a certified Urologist who manages both General Urology and complex Urologic Cancers. He is a Specialist Urology Surgeon who is skilled in working with different treatment choices for optimal outcomes. Treatments he is proficient in include traditional open surgery, advanced keyhole laparoscopic and endoscopic surgery, as well as the modern da Vinci Robotic Surgical Systems. Dr. Chong completed his full-time advanced Clinical Urologic-Oncology Fellowship at the prestigious Memorial Sloan Kettering Cancer Center in New York, the U.S. in 2009. His key professional expertise includes the diagnosis, treatment, and management of prostate, kidney, bladder, testis, and penile cancers.

For Urologic Cancers, Dr. Chong focuses on the following: MRI ultrasound fusion prostate biopsy – To detect prostate cancer accurately with better precision after an MRI prostate scan. Bladder cystoscopy with narrow-band imaging (NBI) – To detect small bladder cancer that is more difficult to diagnose using ordinary white-light cystoscopy.

da Vinci robotic partial nephrectomy – To remove small kidney tumors and save the remaining unaffected kidney. This prevents kidney failure by protecting more kidney function. da Vinci robotic radical prostatectomy – with the removal of pelvic lymph nodes – to treat men with stage 2 and stage 3 prostate cancer and locally-advanced prostate cancer.

For General Urology, Dr. Chong focuses on the following: 1. Enlarged prostate, also known as BPH (benign prostate hyperplasia) – New procedures that are less invasive than traditional resection surgery. Examples include the UroLift, Rezum, and Prolieve procedures.

2. Retrograde intrarenal surgery (RIRS) – Uses a flexible ureteroscope to treat small kidney stones by laser stone surgery. There is no cutting and no surgical scars on the skin.

Prior to private practice, Dr. Chong was the Consultant, Adjunct Assistant Professor, Co-Director of Urologic Oncology, and Director of Research in the Department of Urology at Tan Tock Seng Hospital (TTSH). He also managed the Urology Cancer clinical databases and tissue repository. In the Singapore Cancer Society, he was an Advisory Panel member to improve prostate cancer awareness and survivorship. Dr. Chong is a dynamic healthcare innovator, researcher, and educator. He started molecular research in Urologic-Oncology on prostate cancer immunology in Seattle, Washington, U.S., which was funded by Southwest Oncology Group (SWOG) and Agency for Science, Technology, and Research (A*STAR). While in Singapore, he was a founding member of the Singapore Urological Cancer Consortium and had been in charge of several teams in prostate, kidney, bladder, and testis cancer research. These projects included precision medicine, biomolecular, nanoparticle, bioimaging, and novel biomedical device studies.

To improve holistic care for urological cancer patients in TTSH, Dr. Chong was Chairman of the Urology Cancer Multidisciplinary Tumor Board, Chairman of the Urology Cancer Support Program, and Chairman of the Advance Care Planning Team, and Chairman of the TTSH Prostate Cancer Support Group involving cancer patients and their family.

Dr Chong’s specialty interests are bladder cystoscopy and narrow-band imaging, da Vinci robotic partial nephrectomy, da Vinci robotic radical prostatectomy, MRI ultrasound fusion prostate biopsy, and retrograde intrarenal surgery.

Make an Online Appointment here

Farrer Park Hospital, 1 Farrer Park Station Road, #02-01 Connexion, Singapore 217562.

Read more about  Dr. Chong Chern Hao Park Hospital